Press release
Incyte Announces Recipient of the Inaugural Incyte Ingenuity Award to Recognize Innovative Solutions that Address Needs in the GVHD Community
Massachusetts General Cancer Center awarded $100,000 to launch a patient-centered mobile intervention app for people with chronic graft-versus-host disease
About this update from Incyte Corporation
[{"type":"text","content":"\nMassachusetts General Cancer Center awarded $100,000 to launch a patient-centered mobile intervention app for people with chronic graft-versus-host disease (GVHD)\n\n WILMINGTON, Del.--(BUSINESS WIRE)--\nIncyte (Nasdaq:INCY) today announced that Massachusetts General Cancer Center is the recipient of the first Incyte Ingenuity Award, an annual program that was created to support people living with graft-versus-host disease (GVHD) by encouraging innovative and novel solutions that address specific challenges facing the GVHD community.\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200909005229/en/\n\nMassachusetts General Cancer Center has been awarded $100,000 to implement its project, Horizon Mobile App for Patients with Chronic GVHD – a patient-centered, multi-component mobile intervention app that aims to improve the quality of life and care of patients with chronic GVHD. The Incyte Ingenuity Award applications were reviewed and evaluated by an independent judging panel consisting of Gerry Cowden, Founder, Meredith Cowden Foundation, Shrina Duggal, Pharm. D., BCOP, Clinical Pharmacy Specialist, and Navneet Majhail, M.D., Director, Blood and Marrow Transplant Program, Cleveland Clinic.\n\n\nThe mobile app will consist of an educational game, which will allow a patient character to navigate through a journey as they cope with their chronic GVHD and monitor their progress. The effectiveness of this app will be evaluated via a pilot program, with consideration for a larger expansion.\n\n\n“We are honored to receive the Incyte Ingenuity Award, which will support our institution’s efforts to help advance care for GVHD patients,” said Areej El-Jawahri, M.D., Director of the Bone Marrow Transplant Survivorship Program, Massachusetts General Cancer Center. “Specifically, this award will allow us to support our chronic GVHD patients, who represent a vulnerable population that experiences high degrees of physical and functional limitations, impaired quality of life and significant psychological distress, by developing an app focused on the essential self-management and coping skills that are critical to improving their lives.”\n\n\nIn its inaugural year, several nationally renowned cancer research centers, teaching hospitals and patient advocacy groups applied to receive t...